Athena Philis-Tsimikas

Summary

Affiliation: Scripps Clinic
Country: USA

Publications

  1. pmc Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study
    Stephen R Benoit
    University of California, San Diego, CA, USA
    BMC Public Health 5:36. 2005
  2. ncbi request reprint Improvement in diabetes care of underinsured patients enrolled in project dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model
    Athena Philis-Tsimikas
    Whittier Institute for Diabetes, La Jolla, California 92037, USA
    Diabetes Care 27:110-5. 2004
  3. ncbi request reprint Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program
    Athena Philis-Tsimikas
    The Whittier Institute for Diabetes, Scripps Health, La Jolla, California, USA
    Am J Ther 13:466-72. 2006
  4. ncbi request reprint Outcomes of Project Dulce: a culturally specific diabetes management program
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093 0622, USA
    Ann Pharmacother 39:817-22. 2005
  5. pmc Predictors of dropouts from a San Diego diabetes program: a case control study
    Stephen R Benoit
    UCSD SDSU Preventive Medicine Residency, University of California, San Diego Department of Family and Preventive Medicine, La Jolla, USA
    Prev Chronic Dis 1:A10. 2004
  6. pmc Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, La Jolla, CA, USA
    Diabetes Care 34:1926-31. 2011
  7. ncbi request reprint Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    Athena Philis-Tsimikas
    The Whittier Institute for Diabetes Scripps Health, LaJolla, California 92037, USA
    Clin Ther 28:1569-81. 2006
  8. pmc Precision, accuracy, and user acceptance of the OneTouch SelectSimple blood glucose monitoring system
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, La Jolla, California 92037, USA
    J Diabetes Sci Technol 5:1602-9. 2011
  9. pmc Improving treatment of depression among Latinos with diabetes using project Dulce and IMPACT
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California, USA
    Diabetes Care 31:1324-6. 2008
  10. ncbi request reprint An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update)
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, 9894 Genesee Avenue, Suite 316, La Jolla, CA 92037, USA
    Expert Opin Pharmacother 9:2181-95. 2008

Collaborators

Detail Information

Publications14

  1. pmc Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study
    Stephen R Benoit
    University of California, San Diego, CA, USA
    BMC Public Health 5:36. 2005
    ....
  2. ncbi request reprint Improvement in diabetes care of underinsured patients enrolled in project dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model
    Athena Philis-Tsimikas
    Whittier Institute for Diabetes, La Jolla, California 92037, USA
    Diabetes Care 27:110-5. 2004
    ..To improve clinical diabetes care, patient knowledge, and treatment satisfaction and to reduce health-adverse culture-based beliefs in underserved and underinsured populations with diabetes...
  3. ncbi request reprint Glycemic control with insulin glargine as part of an ethnically diverse, community-based diabetes management program
    Athena Philis-Tsimikas
    The Whittier Institute for Diabetes, Scripps Health, La Jolla, California, USA
    Am J Ther 13:466-72. 2006
    ..To evaluate the contribution of long-acting basal insulin therapy (insulin glargine) to glycemic control in a predominantly Hispanic population participating in a community-based diabetes management program, Project Dulce...
  4. ncbi request reprint Outcomes of Project Dulce: a culturally specific diabetes management program
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093 0622, USA
    Ann Pharmacother 39:817-22. 2005
    ..Diabetes mellitus is a common and costly chronic disease that increasingly affects minority populations; however, there is little evidence regarding the clinical effectiveness and costs of culturally appropriate disease management programs...
  5. pmc Predictors of dropouts from a San Diego diabetes program: a case control study
    Stephen R Benoit
    UCSD SDSU Preventive Medicine Residency, University of California, San Diego Department of Family and Preventive Medicine, La Jolla, USA
    Prev Chronic Dis 1:A10. 2004
    ..The objective of this study was to determine the demographic, treatment, clinical, and behavioral factors associated with dropping out of a nurse-based, low-income, multiethnic San Diego diabetes program...
  6. pmc Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, La Jolla, CA, USA
    Diabetes Care 34:1926-31. 2011
    ....
  7. ncbi request reprint Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    Athena Philis-Tsimikas
    The Whittier Institute for Diabetes Scripps Health, LaJolla, California 92037, USA
    Clin Ther 28:1569-81. 2006
    ..Initial studies investigated detemir administered BID, but pharmacologic data suggest that detemir might be effective with QD administration...
  8. pmc Precision, accuracy, and user acceptance of the OneTouch SelectSimple blood glucose monitoring system
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, La Jolla, California 92037, USA
    J Diabetes Sci Technol 5:1602-9. 2011
    ..Alarms alert subjects to low [20-69 mg/dl (1.1-3.8 mmol/liter)], high [180-239 mg/dl (9.9-13.2 mmol/liter)], and very high [240-600 mg/dl (13.3-33.1 mmol/liter)] blood glucose readings...
  9. pmc Improving treatment of depression among Latinos with diabetes using project Dulce and IMPACT
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California, USA
    Diabetes Care 31:1324-6. 2008
    ..To assess the feasibility and cost of integrating diabetes and depression care management in three community clinics serving a low-income and predominantly Spanish-speaking Latino population...
  10. ncbi request reprint An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update)
    Athena Philis-Tsimikas
    Scripps Whittier Diabetes Institute, 9894 Genesee Avenue, Suite 316, La Jolla, CA 92037, USA
    Expert Opin Pharmacother 9:2181-95. 2008
    ..This article reviews new evidence, in particular on the weight-sparing effect of detemir and its use in type 2 diabetes...
  11. ncbi request reprint Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus
    Daniel Einhorn
    Scripps Whittier Institute for Diabetes, La Jolla, California 92037, USA
    Endocr Pract 13:355-62. 2007
    ..To assess the prevalence of sleep apnea (SA) in adults with type 2 diabetes mellitus (T2DM) and examine whether demographics and comorbid factors were associated with SA in this population...
  12. pmc Cost-effectiveness of diabetes case management for low-income populations
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093 0622, USA
    Health Serv Res 42:1943-59. 2007
    ..To evaluate the cost-effectiveness of Project Dulce, a culturally specific diabetes case management and self-management training program, in four cohorts defined by insurance status...
  13. ncbi request reprint The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
    Octaviano A Roges
    The Whittier Institute for Diabetes, 9894 Genesee Avenue, La Jolla, CA 92037, USA
    Expert Opin Investig Drugs 14:705-27. 2005
    ..This review includes an historical perspective, physiology of incretins, and discussions of the pathophysiology in Type 2 diabetes, pharmacology of the main agents and randomised clinical trials published to date...
  14. ncbi request reprint Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight
    Diane Karl
    The Endocrine Clinic, Portland, Oregon, USA
    Diabetes Technol Ther 9:191-9. 2007
    ..This study was designed to assess the safety and efficacy of pramlintide therapy in patients with type 2 diabetes in a clinical practice setting...